Portal de Periódicos da CAPES

Endocrinology of male puberty

2009; Lippincott Williams & Wilkins; Volume: 16; Issue: 1 Linguagem: Inglês

10.1097/med.0b013e32832029be

1752-2978

Katherine Lewis, Peter A. Lee,

Sexual Differentiation and Disorders

Purpose of review To review recent information leading to a better understanding of the endocrinology of male puberty, including information from earlier stages of life. Recent findings Differences in relative levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in the neonatal period have been further described, as well as changes in inhibin B and anti-Müllerian hormone levels. Studies among men with congenital hypogonadotropic hypogonadism suggest a role for the 'minipuberty of infancy' in inhibin B levels. Gonadotropin-releasing hormone analog-stimulated LH levels at the age of puberty may be useful in diagnosing hypogonadotropic hypogonadism. Inhibin B levels are likewise useful in monitoring spermatogenic activity. Summary Data from fetal life (men born small for gestational age with evidence of a defect in steroidogenesis, relatively high LH:FSH ratio among very premature boys), neonatal period (attenuated rise of inhibin B after rFSH stimulation among men with congenital hypogonadotropic hypogonadism), and puberty (often demonstrable by LH levels alone, progressive rise of insulin-like factor 3 levels, and decrease of anti-Müllerian hormone levels as a consequence of FSH and LH stimulation), all enhance the understanding of the physiology of puberty.